|
English
|
正體中文
|
简体中文
|
2816861
|
|
???header.visitor??? :
27604414
???header.onlineuser??? :
470
???header.sponsordeclaration???
|
|
|
???tair.name??? >
???browser.page.title.author???
|
"fehrenbacher l"???jsp.browse.items-by-author.description???
Showing items 1-4 of 4 (1 Page(s) Totally) 1 View [10|25|50] records per page
臺大學術典藏 |
2020-05-26T09:27:01Z |
ATLAS: Randomized, double-blind, placebo-controlled, phase IIIB trial comparing bevacizumab therapy with or without erlotinib, after completion of chemotherapy, with bevacizumab for first-line treatment of advanced non-small-cell lung cancer
|
Johnson B.E;Kabbinavar F;Fehrenbacher L;Hainsworth J;Kasubhai S;Kressel B;Lin C.-Y;Marsland T;Patel T;Polikoff J;Rubin M;White L;Chih-Hsin Yang;Bowden C;Miller V.; Johnson B.E; Kabbinavar F; Fehrenbacher L; Hainsworth J; Kasubhai S; Kressel B; Lin C.-Y; Marsland T; Patel T; Polikoff J; Rubin M; White L; CHIH-HSIN YANG; Bowden C; Miller V. |
臺大學術典藏 |
2020-05-26T09:27:01Z |
ATLAS: Randomized, double-blind, placebo-controlled, phase IIIB trial comparing bevacizumab therapy with or without erlotinib, after completion of chemotherapy, with bevacizumab for first-line treatment of advanced non-small-cell lung cancer
|
Johnson B.E;Kabbinavar F;Fehrenbacher L;Hainsworth J;Kasubhai S;Kressel B;Lin C.-Y;Marsland T;Patel T;Polikoff J;Rubin M;White L;Chih-Hsin Yang;Bowden C;Miller V.; Johnson B.E; Kabbinavar F; Fehrenbacher L; Hainsworth J; Kasubhai S; Kressel B; Lin C.-Y; Marsland T; Patel T; Polikoff J; Rubin M; White L; CHIH-HSIN YANG; Bowden C; Miller V. |
臺大學術典藏 |
2020-05-26T09:27:00Z |
Biomarker analyses from a randomized, placebo-controlled, phase IIIb trial comparing bevacizumab with or without erlotinib as maintenance therapy for the treatment of Advanced Non-Small-Cell Lung Cancer (ATLAS)
|
Kabbinavar F;Fehrenbacher L;Hainsworth J;Kasubhai S;Kressel B;Marsland T;Patel T;Rubin M;White L;Chih-Hsin Yang;Klughammer B;Colburn D;Miller V;Johnson B.E.; Kabbinavar F; Fehrenbacher L; Hainsworth J; Kasubhai S; Kressel B; Marsland T; Patel T; Rubin M; White L; CHIH-HSIN YANG; Klughammer B; Colburn D; Miller V; Johnson B.E. |
臺大學術典藏 |
2020-05-26T09:27:00Z |
Biomarker analyses from a randomized, placebo-controlled, phase IIIb trial comparing bevacizumab with or without erlotinib as maintenance therapy for the treatment of Advanced Non-Small-Cell Lung Cancer (ATLAS)
|
Kabbinavar F;Fehrenbacher L;Hainsworth J;Kasubhai S;Kressel B;Marsland T;Patel T;Rubin M;White L;Chih-Hsin Yang;Klughammer B;Colburn D;Miller V;Johnson B.E.; Kabbinavar F; Fehrenbacher L; Hainsworth J; Kasubhai S; Kressel B; Marsland T; Patel T; Rubin M; White L; CHIH-HSIN YANG; Klughammer B; Colburn D; Miller V; Johnson B.E. |
Showing items 1-4 of 4 (1 Page(s) Totally) 1 View [10|25|50] records per page
|